16 results
424B5
Zymeworks Inc.
2 Aug 24
Prospectus supplement for primary offering
7:00am
more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer … state drug price transparency and reporting laws that could substantially increase our compliance burdens and expose us to greater liability under
424B5
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:17pm
transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs … transparency and reporting laws that could substantially increase our compliance burdens and expose us to greater liability under such state laws once we
424B5
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:11pm
designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship … are considering or have enacted state drug price transparency and reporting laws that could substantially increase our compliance burdens and expose us to greater
424B5
bcwr6gtpyh4m5v
8 May 23
Prospectus supplement for primary offering
5:19pm
424B5
se3wddq8eqffl
8 May 23
Prospectus supplement for primary offering
5:18pm
424B5
8gn6v872 ksk
9 Nov 22
Prospectus supplement for primary offering
4:29pm
10-Q
p19ir98d9r cju1x6lb
8 Nov 22
Quarterly report
4:09pm
424B5
j2vo1zj8ym5gv1yh0t7
21 Oct 22
Prospectus supplement for primary offering
4:16pm
424B5
c4jiedz
13 Oct 22
Prospectus supplement for primary offering
4:56pm
8-K12B
EX-14.1
igfwk
13 Oct 22
Notification of registration of securities
7:24am
- Prev
- 1
- Next